Should I buy or sell Nutex Health stock right now?

1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Nutex Health in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" NUTX shares. View NUTX analyst ratings or view top-rated stocks .

What is Nutex Health's stock price target for 2024?

1 analysts have issued 12 month price targets for Nutex Health's stock. Their NUTX share price targets range from $15.00 to $15.00. On average, they anticipate the company's stock price to reach $15.00 in the next twelve months. This suggests a possible upside of 2,189.7% from the stock's current price. View analysts price targets for NUTX or view top-rated stocks among Wall Street analysts .

How have NUTX shares performed in 2024?

Nutex Health's stock was trading at $2.70 at the beginning of 2024. Since then, NUTX shares have decreased by 75.7% and is now trading at $0.6551. View the best growth stocks for 2024 here .

Are investors shorting Nutex Health?

Nutex Health saw a drop in short interest in the month of March. As of March 31st, there was short interest totaling 1,030,000 shares, a drop of 29.9% from the March 15th total of 1,470,000 shares. Based on an average daily volume of 2,000,000 shares, the days-to-cover ratio is presently 0.5 days. Currently, 0.2% of the shares of the stock are short sold. View Nutex Health's Short Interest .

When is Nutex Health's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, May 20th 2024. View our NUTX earnings forecast .

When did Nutex Health's stock split?

Nutex Health's stock reverse split on the morning of Wednesday, April 10th 2024. The 1-15 reverse split was announced on Wednesday, April 10th 2024. The number of shares owned by shareholders was adjusted after the market closes on Wednesday, April 10th 2024. An investor that had 100 shares of stock prior to the reverse split would have 7 shares after the split.

Who are Nutex Health's major shareholders?

Nutex Health's stock is owned by many different institutional and retail investors. Top institutional shareholders include One Plus One Wealth Management LLC (0.71%). Insiders that own company stock include John J Waters, Joshua Detillio, Michael Lee Reed, Pamela W Montgomery and Thomas T Vo. View institutional ownership trends .

How do I buy shares of Nutex Health?

Shares of NUTX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

NASDAQ:NUTX

Nutex Health (NUTX) Stock Price, News & Analysis

→ The “Perfect Storm” for Gold (From Gold Safe Exchange) (Ad)

Free NUTX Stock Alerts

$0.70

+0.05 (+6.87%)

(As of 10:04 AM ET)

Compare

Today's Range: $0.63
▼
$0.72
50-Day Range: $0.53
▼
$1.83
52-Week Range: $0.50
▼
$10.92

Volume: 276,476 shs
Average Volume: 230,843 shs
Market Capitalization: $34.81 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: $15.00

Get Nutex Health alerts:

Nutex Health MarketRank™ Stock Analysis

Analyst Rating: Buy
3.00 Rating Score
Upside/Downside: 2,189.7% Upside
$15.00 Price Target
Short Interest: Healthy
0.24% of Float Sold Short
Dividend Strength: N/A
Sustainability: N/A
News Sentiment: -0.11
Based on 3 Articles This Week
Insider Trading: N/A
Proj. Earnings Growth: N/A

Overall MarketRank^™

New Rank-Based ScoringMarketRank^™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

2.67 out of 5 stars

Medical Sector

416th out of 918 stocks

Business Services, Not Elsewhere Classified Industry

60th out of 88 stocks

3.5

Analyst's Opinion

Consensus Rating
Nutex Health has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.
Amount of Analyst Coverage
Nutex Health has only been the subject of 1 research reports in the past 90 days.

5.0

Short Interest

Percentage of Shares Shorted
0.24% of the float of Nutex Health has been sold short.
Short Interest Ratio / Days to Cover
Nutex Health has a short interest ratio ("days to cover") of 0.5, which is generally considered an acceptable ratio of short interest to trading volume.
Change versus previous month
Short interest in Nutex Health has recently decreased by 29.93%, indicating that investor sentiment is improving significantly.

0.0

Dividend Strength

Dividend Yield
Nutex Health does not currently pay a dividend.
Dividend Growth
Nutex Health does not have a long track record of dividend growth.

N/A

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
There is no current Upright™ data available for NUTX.

1.6

News and Social Media Coverage

News Sentiment
Nutex Health has a news sentiment score of -0.11. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.53 average news sentiment score of Medical companies.
News Coverage This Week
MarketBeat has tracked 3 news articles for Nutex Health this week, compared to 1 article on an average week.
Search Interest
Only 5 people have searched for NUTX on MarketBeat in the last 30 days. This is a decrease of -29% compared to the previous 30 days.
MarketBeat Follows
6 people have added Nutex Health to their MarketBeat watchlist in the last 30 days. This is an increase of 200% compared to the previous 30 days.

1.7

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Nutex Health insiders have not sold or bought any company stock.
Percentage Held by Insiders
48.48% of the stock of Nutex Health is held by insiders. A high percentage of insider ownership can be a sign of company health.
Percentage Held by Institutions
Only 5.32% of the stock of Nutex Health is held by institutions.

0.6

Earnings and Valuation

Price to Earnings Ratio vs. the Market
The P/E ratio of Nutex Health is -0.55, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Ratio vs. Sector
The P/E ratio of Nutex Health is -0.55, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Book Value per Share Ratio
Nutex Health has a P/B Ratio of 0.37. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

Ad Altimetry

I’m officially sounding the alarm.

AI has been the hottest financial story of 2023. And rightly so – AI stocks have beat the broader market by over 62%. But right now, my system is warning me that many AI stocks are riding higher on hype alone.

Just click here to watch my full uncensored interview.

About Nutex Health Stock (NASDAQ:NUTX)

Nutex Health Inc. operates as a network of micro-hospitals. It operates through three segments: Hospital, Population Health Management, and Real Estate. The Hospital segment develops and operates a network of micro-hospitals, specialty hospitals and hospital outpatient departments which offers 24/7 care. The Population Health Management segment establishes and operates independent physician associations; and offers a cloud-based platform for healthcare organizations to provide value-based care and population health management. The Real Estate segment leases land and hospital building. It also provides healthcare and facility management services; and healthcare billing, coding, and collection services. In addition, the company offers healthcare services, including emergency room care, inpatient care, and behavioral health, as well as onsite imaging, such as CT scan, X-ray, MRI, ultrasound, etc.; certified and accredited laboratories; and onsite inpatient pharmacies. The company was founded in 2011 and is based in Houston, Texas.

NUTX Stock Price History

30 days | 90 days | 365 days | Advanced Chart

NUTX Stock News Headlines

April 16, 2024 | prnewswire.com

Nutex Health Hospitals Gain Community Recognition and Take Home Seven Patient Satisfaction Awards in Q1

April 13, 2024 | americanbankingnews.com

Nutex Health (NASDAQ:NUTX) Sees Unusually-High Trading Volume

April 19, 2024 | Weiss Ratings (Ad)

The only accurate crypto trading system I know …

Juan Villaverde is no ordinary crypto trader. His proprietary timing algorithm has led him to rack up a series of gains of 477%, 333% and 153% on Bitcoin … It pointed the way to Cardano, at just 4 cents …Helping investors make 29 times their money.

April 12, 2024 | finanznachrichten.de

Nutex Health, Inc.: Nutex Health Provides Corporate Update

April 12, 2024 | prnewswire.com

NUTEX HEALTH PROVIDES CORPORATE UPDATE

April 12, 2024 | americanbankingnews.com

Nutex Health (NASDAQ:NUTX) Reaches New 1-Year Low at $1.03

April 8, 2024 | finance.yahoo.com

NUTEX HEALTH OPENS FIRST HOSPITAL OF 2024 IN BELLEVUE, WISCONSIN

April 5, 2024 | finanznachrichten.de

Nutex Health, Inc.: Nutex Health Announces 1-for-15 Reverse Stock Split

April 19, 2024 | Weiss Ratings (Ad)

The only accurate crypto trading system I know …

April 5, 2024 | investorplace.com

Why Is Nutex Health (NUTX) Stock Down 13% Today?

April 5, 2024 | prnewswire.com

NUTEX HEALTH ANNOUNCES 1-FOR-15 REVERSE STOCK SPLIT

April 1, 2024 | investorplace.com

NUTX Stock Earnings: Nutex Health Misses Revenue for Q4 2023

March 29, 2024 | finanznachrichten.de

Nutex Health, Inc.: Nutex Health Reports Fourth Quarter And Full Year 2023 Financial Results

March 28, 2024 | finance.yahoo.com

NUTEX HEALTH REPORTS FOURTH QUARTER AND FULL YEAR 2023 FINANCIAL RESULTS

March 18, 2024 | investorplace.com

3 Promising Penny Stocks You Can Pick Up for Less Than a Quarter

March 15, 2024 | finanznachrichten.de

Nutex Health, Inc.: Nutex Health Announces Preliminary 2023 Headline Financials And Provides Update On The Timing Of Its 10-k Filing

March 15, 2024 | prnewswire.com

NUTEX HEALTH ANNOUNCES PRELIMINARY 2023 HEADLINE FINANCIALS AND PROVIDES UPDATE ON THE TIMING OF ITS 10-K FILING

February 23, 2024 | benzinga.com

Nutex Health Stock (NASDAQ:NUTX), Analyst Ratings, Price Targets, Predictions

February 5, 2024 | msn.com

Nutex Health's Medicare Advantage membership doubles

February 5, 2024 | finance.yahoo.com

NUTEX HEALTH ANNOUNCES OVER 100% INCREASE IN MEDICARE ADVANTAGE ENROLLMENT

January 31, 2024 | finanznachrichten.de

Nutex Health, Inc.: Nutex Health Announces Streamlined Strategic Plan

January 30, 2024 | finance.yahoo.com

NUTEX HEALTH ANNOUNCES YORKVILLE PAYOFF AND STREAMLINED STRATEGIC PLAN

January 23, 2024 | markets.businessinsider.com

Nutex Prices Direct Offering, Stock Plummets In Pre-market

January 23, 2024 | finance.yahoo.com

Nutex Health Announces Pricing of $10.0 Million Registered Direct Offering of Common Stock and Warrants

January 18, 2024 | finance.yahoo.com

Nutex Health Inc.'s (NASDAQ:NUTX) top owners are retail investors with 47% stake, while 43% is held by insiders

December 18, 2023 | finance.yahoo.com

NUTEX HEALTH TO PRESENT AT THE 42ND ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE

November 27, 2023 | markets.businessinsider.com

Nutex Health Targets To Regain Compliance With Minimum Bid Price Requirement On Or Before May 20

See More Headlines

Receive NUTX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Nutex Health and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Today: 4/19/2024
Next Earnings (Estimated): 5/20/2024
Fiscal Year End: 12/31/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Sector: Medical
Industry: Business services, not elsewhere classified
Sub-Industry: N/A
Current Symbol: NASDAQ:NUTX
CUSIP: N/A
CIK: 1479681
Web: www.nutexhealth.com
Phone: (713) 660-0557
Fax: 631-670-6780
Employees: 1,150
Year Founded: N/A

Price Target and Rating

Average Stock Price Target: $15.00
High Stock Price Target: $15.00
Low Stock Price Target: $15.00
Potential Upside/Downside: +2,189.7%
Consensus Rating: Buy
Rating Score (0-4): 3.00
Research Coverage: 1 Analysts

Profitability

EPS (Most Recent Fiscal Year): ($1.1994)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-45,790,000.00
Net Margins: -18.49%
Pretax Margin: -19.58%
Return on Equity: -45.58%
Return on Assets: -10.50%

Debt

Debt-to-Equity Ratio: 3.04
Current Ratio: 1.56
Quick Ratio: 1.50

Sales & Book Value

Annual Sales: $247.65 million
Price / Sales: 0.13
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: $1.77 per share
Price / Book: 0.37

Miscellaneous

Outstanding Shares: 49,720,000
Free Float: 25,616,000
Market Cap: $32.57 million
Optionable: Not Optionable
Beta: 0.44

Metaverse Stocks And Why You Can't Ignore Them

Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

Key Executives

Dr. Thomas T. Vo M.B.A. (Age 51)
M.D., Chairman of the Board & CEO
Comp: $938.23k
Dr. Warren Hosseinion M.D. (Age 52)
President & Director
Comp: $937.66k
Mr. Jon C. Bates CPA (Age 53)
M.B.A., Chief Financial Officer
Comp: $299.46k
Ms. Pamela W. Montgomery B.S.N. (Age 58)
J.D., L.L.M., M.S.N., R.N., Chief Legal Officer of Healthcare & Board Secretary
Comp: $275.36k
Ms. Elisa Michael Luqman Esq. (Age 60)
J.D., M.B.A., Chief Legal Officer (SEC) & Board Secretary
Comp: $251.33k
Mr. Joshua DeTillio FACHE
M.B.A., Chief Operating Officer
Ms. LaChoenda Rosales
Director of Accounting
LaTanya Brackens
Director of Compliance
Ms. Vivian Sanders M.B.A.
Director of Marketing
Sarah Wallace
Director of Human Resources

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions

NUTX Stock Analysis - Frequently Asked Questions

Should I buy or sell Nutex Health stock right now?: 1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Nutex Health in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" NUTX shares.
View NUTX analyst ratings or view top-rated stocks.
What is Nutex Health's stock price target for 2024?: 1 analysts have issued 12 month price targets for Nutex Health's stock. Their NUTX share price targets range from $15.00 to $15.00. On average, they anticipate the company's stock price to reach $15.00 in the next twelve months. This suggests a possible upside of 2,189.7% from the stock's current price.
View analysts price targets for NUTX or view top-rated stocks among Wall Street analysts.
How have NUTX shares performed in 2024?: Nutex Health's stock was trading at $2.70 at the beginning of 2024. Since then, NUTX shares have decreased by 75.7% and is now trading at $0.6551.
View the best growth stocks for 2024 here.
Are investors shorting Nutex Health?: Nutex Health saw a drop in short interest in the month of March. As of March 31st, there was short interest totaling 1,030,000 shares, a drop of 29.9% from the March 15th total of 1,470,000 shares. Based on an average daily volume of 2,000,000 shares, the days-to-cover ratio is presently 0.5 days. Currently, 0.2% of the shares of the stock are short sold.
View Nutex Health's Short Interest.

When is Nutex Health's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Monday, May 20th 2024.
View our NUTX earnings forecast.
When did Nutex Health's stock split?: Nutex Health's stock reverse split on the morning of Wednesday, April 10th 2024. The 1-15 reverse split was announced on Wednesday, April 10th 2024. The number of shares owned by shareholders was adjusted after the market closes on Wednesday, April 10th 2024. An investor that had 100 shares of stock prior to the reverse split would have 7 shares after the split.
Who are Nutex Health's major shareholders?: Nutex Health's stock is owned by many different institutional and retail investors. Top institutional shareholders include One Plus One Wealth Management LLC (0.71%). Insiders that own company stock include John J Waters, Joshua Detillio, Michael Lee Reed, Pamela W Montgomery and Thomas T Vo.
View institutional ownership trends.
How do I buy shares of Nutex Health?: Shares of NUTX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:NUTX) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial